Author Description

This 3rd edition has been broadened in its name and scope with the addition of cellular products. Other key revisions include revised requirements for consistency with FDAs proposed good tissue practice regulations, new requirements for interface between collecting and administering facilities, revised donor qualification requirements, new processing tests and new record retention timeframes consistent with proposed GTP requirements.